Ly Thi Tran

Title: The Innovative Contributions of Ly Thi Tran

Introduction

Ly Thi Tran is a notable inventor based in Moss, Norway. He has made significant contributions to the field of medical diagnostics, particularly through his innovative patent related to NT-proBNP quantification. His work has implications for improving clinical assessments and patient care.

Latest Patents

Ly Thi Tran holds a patent for a highly sensitive particle-enhanced assay for the quantification of NT-proBNP. This assay allows for the determination of NT-proBNP in biological samples using at least one antibody that recognizes an epitope of NT-proBNP in both glycosylated and non-glycosylated forms. The preferred antibody is an isolated polyclonal antibody or a mixture of monoclonal antibodies coated onto a particle. The coating ratio of antibodies on the particle ranges from 6-60%, forming a layer or multiple layers of antibodies. This assay can be realized in the form of a nephelometric or turbidimetric assay and is applicable to a wide range of automated clinical analyzers.

Career Highlights

Ly Thi Tran is currently associated with Gentian AS, where he continues to develop innovative solutions in the field of diagnostics. His expertise and dedication to research have positioned him as a valuable asset in his organization.

Collaborations

Some of his notable coworkers include Ingvild Gudim and Torsten Knüttel, who contribute to the collaborative environment that fosters innovation and research excellence.

Conclusion

Ly Thi Tran's contributions to medical diagnostics through his patent on NT-proBNP quantification exemplify the impact of innovation in healthcare. His work continues to influence clinical practices and improve patient outcomes.